Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole ER vs IR and Placebo in Early Parkinson's Disease
NCT00479401Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Started May 2007; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00479401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479401.